At MoleSafe, we are dedicated to revolutionizing skin health and empowering individuals to prioritize their well-being through innovative technology and expert dermatological care. Our AI-driven platform serves as a vital tool in the fight against skin cancer, the most prevalent form of cancer in the United States. By providing comprehensive imaging and early detection of potential risks, we strive to save lives and reduce the impact of this disease on individuals and communities. We are committed to advancing skin health through innovation, education, and compassionate care, ensuring that everyone has access to the tools and support needed to protect their skin and overall health.
Molesafe has established a durable partnership with DermEngine, a Canadian technology firm leveraging AI-supported software, to proficiently capture images of human skin for evaluation. Within the DermEngine software, Molesafe has integrated its own distinctive proprietary workflow to efficiently capture high-quality, medical-grade images. These images are then interpreted by our team of dermatological physicians, specializing in skin cancer screening.
Driven by a commitment to address a significant gap in the prevention and management of skin cancer, the most prevalent form of cancer in the U.S., Molesafe is pioneering a new vertical in healthcare. With a scalable infrastructure in place, Molesafe aims to expand rapidly and become a national platform serving the 338 million Americans at risk of skin cancer.
Currently operating four Molesafe facilities, including one in Manhattan and three in New Jersey, Molesafe is poised for growth. The company is now seeking to license its technology to hospital systems and large physician groups. This strategic move aims to elevate awareness of Molesafe
We believe in the power of early detection to save lives. Our mission is to prevent skin cancer before it becomes a threat.
By leveraging cutting-edge AI technology, we ensure that our patients receive the most accurate and timely diagnoses.
We maintain the highest ethical standards in everything we do, fostering trust with our patients, partners, and community.
We are dedicated to continuous improvement, ensuring that our methods, technology, and services are always at the forefront of skin cancer prevention.
Working with healthcare professionals, researchers, and technologists, we aim to push the boundaries of what’s possible in skin cancer detection.
Dr. Randy Nissinoff, CEO and Managing Member of MoleSafe USA, is a healthcare innovator with over 20 years of experience in healthcare, retail, and franchising. As an optometrist, he understands the critical role of physicians both in and outside the exam room. Dr. Nissinoff grew a single Pearle Vision franchise into a 21-unit company and successfully led a private equity transaction. As a CEO, he excels in building strong company cultures, developing high-performance teams, and creating strategic growth plans grounded in financial and operational excellence. His expertise spans financial planning, team leadership, operational strategy, and healthcare innovation. Now focused on leading MoleSafe, he applies his diverse skill set to drive growth and excellence in skin health
Dr. Randy Nissinoff, CEO and Managing Member of MoleSafe USA, is a healthcare innovator with over 20 years of experience in healthcare, retail, and franchising. As an optometrist, he understands the critical role of physicians both in and outside the exam room. Dr. Nissinoff grew a single Pearle Vision franchise into a 21-unit company and successfully led a private equity transaction. As a CEO, he excels in building strong company cultures, developing high-performance teams, and creating strategic growth plans grounded in financial and operational excellence. His expertise spans financial planning, team leadership, operational strategy, and healthcare innovation. Now focused on leading MoleSafe, he applies his diverse skill set to drive growth and excellence in skin health
Dr. Randy Nissinoff, CEO and Managing Member of MoleSafe USA, is a healthcare innovator with over 20 years of experience in healthcare, retail, and franchising. As an optometrist, he understands the critical role of physicians both in and outside the exam room. Dr. Nissinoff grew a single Pearle Vision franchise into a 21-unit company and successfully led a private equity transaction. As a CEO, he excels in building strong company cultures, developing high-performance teams, and creating strategic growth plans grounded in financial and operational excellence. His expertise spans financial planning, team leadership, operational strategy, and healthcare innovation. Now focused on leading MoleSafe, he applies his diverse skill set to drive growth and excellence in skin health
is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s
is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s
General Inquiries: contact@molesafe.com
You may cancel or reschedule your appointment up to 48 hours before to be entitled to a refund.